← FDA Drug Approvals (Drugs@FDA)
TAZAROTENE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: COSETTE · Approved 2022-09-13
Drug application
- FDA Application #
ANDA215433- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TAZAROTENE
- Generic name
- TAZAROTENE
- Active ingredients
- TAZAROTENE
- Dosage form
- GEL
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- COSETTE
- Manufacturer
- Cosette Pharmaceuticals, Inc.
- First approval
- 2022-09-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown